XNAS
ACB
Market cap933mUSD
Jul 09, Last price
2.70USD
1D
0.75%
1Q
-21.28%
Jan 2017
-98.69%
IPO
-97.51%
Name
Aurora Cannabis Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Aurora Cannabis Inc., based in Edmonton, Canada, is a global enterprise focused on the cultivation, distribution, and sale of cannabis and cannabis-derived goods. Within Canada, the company provides both medical and recreational cannabis products. Its international operations include supplying wholesale medical cannabis to various regions, such as the European Union, Australia, the Caribbean, South America, and Israel. Additionally, Aurora distributes and sells hemp-derived cannabidiol (CBD) products within the United States market. The company's product offerings are extensive, featuring dried cannabis, cannabis oils, capsules, edible cannabis, and concentrated extracts. These products can be consumed through various methods, including smoking, vaporizing, or ingestion in oil, capsule, edible, or extract forms. Aurora also offers dried milled strains and specific cannabis oil formulations, alongside patient counseling and outreach services. Its adult-use brand collection features names like Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, while its CBD offerings include Reliva and KG7. For medical cannabis patients, the company provides brands such as MedReleaf, CanniMed, Aurora, and WMMC.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||